Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 98
Filter
2.
Int J Mol Sci ; 25(15)2024 Jul 23.
Article in English | MEDLINE | ID: mdl-39125585

ABSTRACT

Acute respiratory distress syndrome (ARDS) occurs as an acute onset condition, and patients present with diffuse alveolar damage, refractory hypoxemia, and non-cardiac pulmonary edema. ARDS progresses through an initial exudative phase, an inflammatory phase, and a final fibrotic phase. Pirfenidone, a powerful anti-fibrotic agent, is known as an agent that inhibits the progression of fibrosis in idiopathic pulmonary fibrosis. In this study, we studied the treatment efficiency of pirfenidone on lipopolysaccharide (LPS) and bleomycin-induced ARDS using rats. The ARDS rat model was created by the intratracheal administration of 3 mg/kg LPS of and 3 mg/kg of bleomycin dissolved in 0.2 mL of normal saline. The pirfenidone treatment group was administered 100 or 200 mg/kg of pirfenidone dissolved in 0.5 mL distilled water orally 10 times every 2 days for 20 days. The administration of LPS and bleomycin intratracheally increased lung injury scores and significantly produced pro-inflammatory cytokines. ARDS induction increased the expressions of transforming growth factor (TGF)-ß1/Smad-2 signaling factors. Additionally, matrix metalloproteinase (MMP)-9/tissue inhibitor of metalloproteinase (TIMP)-1 imbalance occurred, resulting in enhanced fibrosis-related factors. Treatment with pirfenidone strongly suppressed the expressions of TGF-ß1/Smad-2 signaling factors and improved the imbalance of MMP-9/TIMP-1 compared to the untreated group. These effects led to a decrease in fibrosis factors and pro-inflammatory cytokines, promoting the recovery of damaged lung tissue. These results of this study showed that pirfenidone administration suppressed inflammation and fibrosis in the ARDS animal model. Therefore, pirfenidone can be considered a new early treatment for ARDS.


Subject(s)
Bleomycin , Lipopolysaccharides , Pyridones , Respiratory Distress Syndrome , Signal Transduction , Animals , Pyridones/pharmacology , Pyridones/therapeutic use , Respiratory Distress Syndrome/drug therapy , Respiratory Distress Syndrome/metabolism , Respiratory Distress Syndrome/pathology , Respiratory Distress Syndrome/chemically induced , Signal Transduction/drug effects , Rats , Male , Bleomycin/adverse effects , Tissue Inhibitor of Metalloproteinase-1/metabolism , Smad2 Protein/metabolism , Rats, Sprague-Dawley , Inflammation/drug therapy , Inflammation/metabolism , Inflammation/pathology , Disease Models, Animal , Matrix Metalloproteinase 9/metabolism , Transforming Growth Factor beta1/metabolism , Transforming Growth Factor beta/metabolism , Lung/pathology , Lung/drug effects , Lung/metabolism , Smad Proteins/metabolism
3.
Article in English | MEDLINE | ID: mdl-39173738

ABSTRACT

Colistin is considered the last resort for treating infections caused by multidrug-resistant bacteria. However, the spread of the plasmid-borne colistin-resistance gene mcr-1 has become a public health threat. In this study, we identified mcr-1-harboring Leclercia adecarboxylata strain (WWCOL-134) isolated from wastewater in Seoul. The strain had a colistin MIC value of 2 µg/ml and was resistant to cefotaxime, gentamicin, tetracycline, trimethoprim, and sulfamethoxazole. The mcr-1 gene, along with an array of resistance genes, was located on a 236-kb plasmid (pCOL134-1), which contained the typical IncHI2 backbone of reported mcr-1-carrying plasmids, and was transferred to an Escherichia coli strain by conjugation. To the best of our knowledge, this is the first study to report the emergence of mcr-1-harboring Leclercia sp. isolate. Our findings demonstrate the ongoing spread of colistin resistance among Enterobacterales species, emphasizing the need for surveillance of antimicrobial resistance in wastewater environments.

4.
Sci Rep ; 13(1): 18805, 2023 11 01.
Article in English | MEDLINE | ID: mdl-37914747

ABSTRACT

The TARDBP gene variant is a known major cause of amyotrophic lateral sclerosis (ALS), with limited reports of Korean patients with ALS harboring the variants in TARDBP. This large cohort study introduces four ALS patients who share the p.M337V variant of the TARDBP, allowing for an investigation of clinical characteristics and prognosis by analyzing previously reported cases with the same variant. From November 2014 to August 2022, participants were recruited from two tertiary hospitals in Seoul, Korea. Clinical characteristics of patients diagnosed with ALS carrying the variant in TARDBP were evaluated. Previous articles demonstrating subjects' characteristics were reviewed. Four patients were identified with the pathogenic missense variant (c.1009A>G; p.M337V) in the TARDBP. The mean age of onset was 55 years old, and none of the patients showed severe cognitive impairment. Sixty-three patients carrying the p.M337V variant in TARDBP from this study and previous reports delineated young age of onset (51.6 years), high frequency of bulbar onset patients (61.9%), and low comorbidity of frontotemporal dementia. This study reveals the presence of pathogenic variant of TARDBP in Korea and emphasizes the importance of genetic screening of the TARDBP gene, in diagnosing ALS and evaluating prognosis among familial and simplex ALS patients in Korea.


Subject(s)
Amyotrophic Lateral Sclerosis , Humans , Middle Aged , Amyotrophic Lateral Sclerosis/epidemiology , Amyotrophic Lateral Sclerosis/genetics , Amyotrophic Lateral Sclerosis/pathology , Cohort Studies , Genetic Testing , Mutation , Mutation, Missense , Republic of Korea/epidemiology
5.
PLoS One ; 18(10): e0292460, 2023.
Article in English | MEDLINE | ID: mdl-37831677

ABSTRACT

The available quantitative methods for evaluating bulbar dysfunction in patients with amyotrophic lateral sclerosis (ALS) are limited. We aimed to characterize vowel properties in Korean ALS patients, investigate associations between vowel parameters and clinical features of ALS, and analyze subclinical articulatory changes of vowel parameters in those with perceptually normal voices. Forty-three patients with ALS (27 with dysarthria and 16 without dysarthria) and 20 healthy controls were prospectively collected in the study. Dysarthria was assessed using the ALS Functional Rating Scale-Revised (ALSFRS-R) speech subscores, with any loss of 4 points indicating the presence of dysarthria. The structured speech samples were recorded and analyzed using Praat software. For three corner vowels (/a/, /i/, and /u/), data on the vowel duration, fundamental frequency, frequencies of the first two formants (F1 and F2), harmonics-to-noise ratio, vowel space area (VSA), and vowel articulation index (VAI) were extracted from the speech samples. Corner vowel durations were significantly longer in ALS patients with dysarthria than in healthy controls. The F1 frequency of /a/, F2 frequencies of /i/ and /u/, the VSA, and the VAI showed significant differences between ALS patients with dysarthria and healthy controls. The area under the curve (AUC) was 0.912. The F1 frequency of /a/ and the VSA were the major determinants for differentiating ALS patients who had not yet developed apparent dysarthria from healthy controls (AUC 0.887). In linear regression analyses, as the ALSFRS-R speech subscore decreased, both the VSA and VAI were reduced. In contrast, vowel durations were found to be rather prolonged. The analyses of vowel parameters provided a useful metric correlated with disease severity for detecting subclinical bulbar dysfunction in ALS patients.


Subject(s)
Amyotrophic Lateral Sclerosis , Dysarthria , Humans , Dysarthria/diagnosis , Dysarthria/etiology , Speech Intelligibility , Phonetics , Republic of Korea , Speech Acoustics
6.
Sci Rep ; 13(1): 14360, 2023 09 01.
Article in English | MEDLINE | ID: mdl-37658148

ABSTRACT

Ewing sarcoma (EWS) is a malignant tumor arising in bone or soft tissue that occurs in adolescent and young adult patients as well as adults later in life. Although non-metastatic EWS is typically responsive to treatment when newly diagnosed, relapsed cases have an unmet need for which no standard treatment approach exists. Recent phase III clinical trials for EWS comparing 7 vs 5 chemotherapy drugs have failed to improve survival. To extend the durability of remission for EWS, we investigated 3 non-chemotherapy adjuvant therapy drug candidates to be combined with chemotherapy. The efficacy of these adjuvant drugs was investigated via anchorage-dependent growth assays, anchorage-independent soft-agar colony formation assays and EWS xenograft mouse models. Enoxacin and entinostat were the most effective adjuvant drug in both long-term in vitro and in vivo adjuvant studies. In the context that enoxacin is an FDA-approved antibiotic, and that entinostat is an investigational agent not yet FDA-approved, we propose enoxacin as an adjuvant drug for further preclinical and clinical investigation in EWS patients.


Subject(s)
Neuroectodermal Tumors, Primitive, Peripheral , Sarcoma, Ewing , Humans , Animals , Mice , Sarcoma, Ewing/drug therapy , Enoxacin , Benzamides , Adjuvants, Immunologic , Adjuvants, Pharmaceutic , Disease Models, Animal , Tumor Suppressor Protein p53
7.
J Clin Virol ; 164: 105497, 2023 07.
Article in English | MEDLINE | ID: mdl-37253299

ABSTRACT

BACKGROUND: Rotavirus group A (RVA) is a causative agent of acute gastroenteritis among young children worldwide, despite the global expansion of rotavirus vaccination. In Korea, although the prevalence of RVA has been reduced among young children owing to vaccination, nosocomial infections still occur among neonates. OBJECTIVES: The aim of this study was to investigate the molecular epidemiology of RVA strains associated with several neonatal outbreaks in Seoul from 2017 to 2020. STUDY DESIGN: Clinical and environmental samples were collected and screened for the presence of RVA using ELISA and PCR targeting VP6, respectively. RVA-positive strains were genotyped via RT-PCR and subsequent sequencing of VP4 and VP7 and were phylogenetically compared with RVA strains from other countries. RESULTS: During 2017-2020, a total of 15 RVA outbreaks occurred at neonatal facilities (six in hospital neonatal wards and nine in postpartum care centers) in Seoul, and only two RVA genotypes were detected: G4P[6] and G8P[6]. G8P[6] emerged in Seoul November 2018 and immediately became the predominant genotype among neonates, at least up to 2020. Phylogenetic analysis revealed that the G8P[6] genotype in this study was closely related to G8P[6] strains first identified in Korea in 2017, but differed from G8P[6] strains detected in Africa. CONCLUSIONS: A novel G8P[6] genotype of RVA strains has emerged and caused outbreaks among neonates in Seoul. Continued surveillance for circulating RVA genotypes is imperative to monitor genotype changes and their potential risks to public health.


Subject(s)
Cross Infection , Disease Outbreaks , Molecular Epidemiology , Phylogeny , Rotavirus Infections , Rotavirus , Female , Humans , Infant, Newborn , Feces/virology , Genotype , Rotavirus/genetics , Rotavirus Infections/epidemiology , Rotavirus Infections/virology , Seoul/epidemiology , Cross Infection/epidemiology , Cross Infection/virology , Capsid Proteins/genetics , Environmental Microbiology , Male
8.
Sci Rep ; 13(1): 5528, 2023 04 04.
Article in English | MEDLINE | ID: mdl-37016037

ABSTRACT

Dysregulation of microRNAs (miRNA) in small extracellular vesicles (sEV) such as exosomes have been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS). Although circulating cell-free miRNA have been extensively investigated in ALS, sEV-derived miRNAs have not been systemically explored yet. Here, we performed small RNA sequencing analysis of serum sEV and identified 5 differentially expressed miRNA in a discovery cohort of 12 patients and 11 age- and sex-matched healthy controls (fold change > 2, p < 0.05). Two of them (up- and down-regulation of miR-23c and miR192-5p, respectively) were confirmed in a separate validation cohort (18 patients and 15 healthy controls) by droplet digital PCR. Bioinformatic analysis revealed that these two miRNAs interact with distinct sets of target genes and involve biological processes relevant to the pathomechanism of ALS. Our results suggest that circulating sEV from ALS patients have distinct miRNA profiles which may be potentially useful as a biomarker of the disease.


Subject(s)
Amyotrophic Lateral Sclerosis , Circulating MicroRNA , Extracellular Vesicles , MicroRNAs , Humans , Amyotrophic Lateral Sclerosis/pathology , Circulating MicroRNA/genetics , MicroRNAs/genetics , Extracellular Vesicles/genetics , Extracellular Vesicles/pathology , Sequence Analysis, RNA
10.
Materials (Basel) ; 15(19)2022 Oct 02.
Article in English | MEDLINE | ID: mdl-36234184

ABSTRACT

We propose an efficient alignment method for liquid crystals (LCs). A brush-coating method handles film deposition and LC alignment treatment simultaneously herein, meaning a reduction in the conventional alignment layer treatment process steps. A lanthanum yttrium strontium oxide (LaYSrO) film prepared by the sol-gel process was used for the alignment layer. Topographical details of the brush-coated LaYSrO films (compared with spin-coated films) were investigated by atomic force microscopy. Spin-coated LaYSrO meant that the film formation alone without orientation treatment represented an isotropic surface. On the other hand, the 270 °C-cured brush-coated LaYSrO showed nano/microstructure with directionality. It indicates that brush-hair sweeping induced shearing stress on the sol state of the LaYSrO, which results in surface anisotropy for LC alignment. The uniform LC alignment state was confirmed by polarized optical microscopy and pretilt analysis. The brush-coated LaYSrO shows fine optical transparency compared to plain and indium-tin-oxide coated glasses, and thermal stability up to 150 °C for LC alignment. Competitive electro-optical performances of the brush-coated LaYSrO were verified in a twisted-nematic LC system compared to those of the conventionally used polyimide layer. Consequently, we expect that the brush-coating process can be an innovative technology for LC alignment.

11.
Biochem Biophys Res Commun ; 621: 101-108, 2022 09 17.
Article in English | MEDLINE | ID: mdl-35820279

ABSTRACT

Over the past 25 years, chemotherapy regimens for osteosarcoma have failed to improve the 65-70% long-term survival rate. Radiation therapy is generally ineffective except for palliative care. We here investigated whether osteosarcoma can be sensitized to radiation therapy targeting specific molecules in osteosarcoma. Large-scale RNA sequencing analysis in osteosarcoma tissues and cell lines revealed that FGFR1 is the most frequently expressed receptor tyrosine kinase in osteosarcoma. Nuclear FGFR1 (nFGFR1) was observed by subcellular localization assays. The functional studies using a FGFR1IIIb antibody or small molecule FGFR1 inhibitors showed that nFGFR1, but not membrane-bound FGFR1, induces G2 cell-cycle checkpoint adaptation, cell survival and polyploidy following irradiation in osteosarcoma cells. Further, the activation of nFGFR1 induces Histone H3 phosphorylation at Ser 10 and c-jun/c-fos expression to contribute cell survival rendering radiation resistance. Furthermore, an in vivo mouse study revealed that radiation resistance can be reversed by the inhibition of nFGFR1. Our findings provide insights into the potential role of nFGFR1 to radiation resistance. Thus, we propose nFGFR1 could be a potential therapeutic target or a biomarker to determine which patients might benefit from radiation therapy.


Subject(s)
Bone Neoplasms , Osteosarcoma , Animals , Bone Neoplasms/drug therapy , Bone Neoplasms/genetics , Bone Neoplasms/radiotherapy , Cell Line, Tumor , Cell Nucleus/metabolism , Cell Survival , Humans , Mice , Osteosarcoma/drug therapy , Osteosarcoma/genetics , Osteosarcoma/radiotherapy , Phosphorylation , Receptor, Fibroblast Growth Factor, Type 1/genetics , Receptor, Fibroblast Growth Factor, Type 1/metabolism
12.
Chest ; 161(6): e377-e382, 2022 06.
Article in English | MEDLINE | ID: mdl-35680319

ABSTRACT

CASE PRESENTATION: An 87-year-old woman with a medical history of stroke, paroxysmal atrial fibrillation, type 2 diabetes mellitus, diastolic heart failure, and chronic bilateral lymphedema presents with 1 week of shortness of breath. The patient had a 20-pack-year smoking history and at baseline was able to ambulate freely without assistance. Her symptoms of dyspnea were mostly exertional and progressively worsening for 1 week before admission, despite compliance with her home furosemide. On admission, her temperature was 36.3 °C, BP was 101/59 mm Hg, heart rate was 82 beats/min, respirations were 18 breaths/min, and oxygen saturation was 91% on room air. On physical examination, the patient was tachypneic at rest, and auscultation of the lungs revealed minimal breath sounds on the left side. Admission laboratory test results were notable for leukocyte count of 11.67 × 109/L (82.2% neutrophils, 8.3% monocytes, 6.4% lymphocytes, and 2.1% eosinophils). Results of HIV screening tests were negative.


Subject(s)
Diabetes Mellitus, Type 2 , Stroke , Aged, 80 and over , Dyspnea/diagnosis , Dyspnea/etiology , Female , Humans , Lung
13.
Cell Death Dis ; 13(4): 374, 2022 04 19.
Article in English | MEDLINE | ID: mdl-35440077

ABSTRACT

Triple-negative breast cancer (TNBC) is a heterogeneous disease characterized by poor response to standard therapies and therefore unfavorable clinical outcomes. Better understanding of TNBC and new therapeutic strategies are urgently needed. ROR nuclear receptors are multifunctional transcription factors with important roles in circadian pathways and other processes including immunity and tumorigenesis. Nobiletin (NOB) is a natural compound known to display anticancer effects, and our previous studies showed that NOB activates RORs to enhance circadian rhythms and promote physiological fitness in mice. Here, we identified several TNBC cell lines being sensitive to NOB, by itself or in combination. Cell and xenograft experiments showed that NOB significantly inhibited TNBC cell proliferation and motility in vitro and in vivo. ROR loss- and gain-of-function studies showed concordant effects of the NOB-ROR axis on MDA-MB-231 cell growth. Mechanistically, we found that NOB activates ROR binding to the ROR response elements (RRE) of the IκBα promoter, and NOB strongly inhibited p65 nuclear translocation. Consistent with transcriptomic analysis indicating cancer and NF-κB signaling as major pathways altered by NOB, p65-inducible expression abolished NOB effects, illustrating a requisite role of NF-κB suppression mediating the anti-TNBC effect of NOB. Finally, in vivo mouse xenograft studies showed that NOB enhanced the antitumor efficacy in mammary fat pad implanted TNBC, as a single agent or in combination with the chemotherapy agent Docetaxel. Together, our study highlights an anti-TNBC mechanism of ROR-NOB via suppression of NF-κB signaling, suggesting novel preventive and chemotherapeutic strategies against this devastating disease.


Subject(s)
Flavones , Triple Negative Breast Neoplasms , Animals , Cell Line, Tumor , Cell Proliferation , Flavones/pharmacology , Flavones/therapeutic use , Humans , I-kappa B Kinase/metabolism , Mice , NF-kappa B/metabolism , Signal Transduction , Triple Negative Breast Neoplasms/pathology , Xenograft Model Antitumor Assays
14.
BMC Pediatr ; 22(1): 143, 2022 03 17.
Article in English | MEDLINE | ID: mdl-35300646

ABSTRACT

BACKGROUND: During puberty, changes in body composition due to sex hormones are associated with lung mechanics. However, little is known about the mediation effect of sex differences in body composition during puberty with total airway resistance. METHODS: We prospectively recruited 620 children (10-12 years old) from the general population and conducted a cross-sectional study. This study assessed pubertal status according to the five Tanner stages using a questionnaire, line drawings, and each subject's blood sex hormone profile. Both the impulse oscillation system for total lung mechanics and multifrequency bioelectrical impedance for body composition analyses were conducted. The effects of puberty on body composition and subsequent total lung resistance were evaluated using mediation analysis. RESULTS: Among the 503 children enrolled, there were 261 males (51.9%) and 242 females (48.1%). In males, higher testosterone levels corresponded with reduced total lung resistance (ß = -0.13, 95% CI = -0.21 to -0.05, p < 0.001), and the proportion of the mediating effect through the muscle-fat ratio was 19% (95% CI = 4 to 59, p = 0.02). In contrast, in females, pubertal status reduced total lung resistance (ß = -0.27, 95% CI = -0.58 to -0.05, p = 0.04), however, the proportion of the mediating effect through the body mass index was -51% (95% CI = -244 to -4%, p = 0.04). CONCLUSION: The muscle-fat ratio in adolescent males had a synergistic effect with testosterone on improving total airway resistance, whereas improvements in lung resistance by pubertal status were partially masked by body mass index in adolescent females. In conclusion, body composition changes during puberty between males and females have differing effects on total airway resistance.


Subject(s)
Airway Resistance , Sex Characteristics , Adolescent , Body Composition , Body Mass Index , Child , Cross-Sectional Studies , Female , Humans , Lung , Male , Puberty , Testosterone
15.
Oncogene ; 41(11): 1647-1656, 2022 03.
Article in English | MEDLINE | ID: mdl-35094009

ABSTRACT

Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and phenocopies a muscle precursor that fails to undergo terminal differentiation. The alveolar subtype (ARMS) has the poorest prognosis and represents the greatest unmet medical need for RMS. Emerging evidence supports the role of epigenetic dysregulation in RMS. Here we show that SMARCA4/BRG1, an ATP-dependent chromatin remodeling enzyme of the SWI/SNF complex, is prominently expressed in primary tumors from ARMS patients and cell cultures. Our validation studies for a CRISPR screen of 400 epigenetic targets identified SMARCA4 as a unique factor for long-term (but not short-term) tumor cell survival in ARMS. A SMARCA4/SMARCA2 protein degrader (ACBI-1) demonstrated similar long-term tumor cell dependence in vitro and in vivo. These results credential SMARCA4 as a tumor cell dependency factor and a therapeutic target in ARMS.


Subject(s)
Neoplasms , Rhabdomyosarcoma, Alveolar , Rhabdomyosarcoma, Embryonal , Biology , Child , DNA Helicases/genetics , Humans , Nuclear Proteins/genetics , Rhabdomyosarcoma, Alveolar/genetics , Transcription Factors/genetics
18.
Article in English | MEDLINE | ID: mdl-34206381

ABSTRACT

BACKGROUND: As the service industry develops, the proportion of emotional laborers is gradually increasing, and their occupational health problems are gradually becoming serious social problems. Researchers must consider various factors, from the personal to the organizational levels, to prevent health problems from arising in the workplace. Many intervention studies have investigated the health and wellbeing of workers, but mainly at the individual level, even though an organization's interest and efforts are essential for addressing work-related health problems. Therefore, the purpose of this study was to verify the importance of organizations' interests to protect emotional laborers from work-related health problems. METHODS: We used data obtained through the 4th Korean Working Condition Survey of 2014. The study cohort comprised 5857 survey participants over the age of 18 years. Employers, self-employed persons and professional soldiers were excluded. Logistic regression was employed to identify associations between an emotional expression guide and work-related health problems using SPSS 22.0 statistical software. RESULTS: In the absence of an emotional expression guide, the risk of work-related physical and psychological health problems was increased. Even after adjusting for confounding variables, the risks were statistically maintained, particularly headache (odds ratio (OR) 1.798; 95% confidence interval 95% CI: 1.288-2.508), lower limb muscular pain (OR: 1.627; 95% CI: 1.130-2.342), general fatigue (OR: 1.582; 95% CI: 1.077-2.326) and depressive symptom (OR: 6.149; 95% CI: 1.198-31.563). CONCLUSION: This study showed that organizations' interests and efforts to prevent workers from being harmed by the effects of emotional labor are important in the prevention of psychosocial and physical health problems; therefore, a national interest in supporting emotional laborers and in introducing policies to support these workers should be established.


Subject(s)
Occupational Health , Workplace , Adult , Emotions , Humans , Middle Aged , Occupations , Surveys and Questionnaires
19.
Neurooncol Adv ; 3(1): vdab039, 2021.
Article in English | MEDLINE | ID: mdl-34013206

ABSTRACT

BACKGROUND: Diffuse intrinsic pontine glioma (DIPG) is a devastating pediatric cancer with unmet clinical need. DIPG is invasive in nature, where tumor cells interweave into the fiber nerve tracts of the pons making the tumor unresectable. Accordingly, novel approaches in combating the disease are of utmost importance and receptor-driven cell invasion in the context of DIPG is under-researched area. Here, we investigated the impact on cell invasion mediated by PLEXINB1, PLEXINB2, platelet growth factor receptor (PDGFR)α, PDGFRß, epithelial growth factor receptor (EGFR), activin receptor 1 (ACVR1), chemokine receptor 4 (CXCR4), and NOTCH1. METHODS: We used previously published RNA-sequencing data to measure gene expression of selected receptors in DIPG tumor tissue versus matched normal tissue controls (n = 18). We assessed protein expression of the corresponding genes using DIPG cell culture models. Then, we performed cell viability and cell invasion assays of DIPG cells stimulated with chemoattractants/ligands. RESULTS: RNA-sequencing data showed increased gene expression of receptor genes such as PLEXINB2, PDGFRα, EGFR, ACVR1, CXCR4, and NOTCH1 in DIPG tumors compared to the control tissues. Representative DIPG cell lines demonstrated correspondingly increased protein expression levels of these genes. Cell viability assays showed minimal effects of growth factors/chemokines on tumor cell growth in most instances. Recombinant SEMA4C, SEM4D, PDGF-AA, PDGF-BB, ACVA, CXCL12, and DLL4 ligand stimulation altered invasion in DIPG cells. CONCLUSIONS: We show that no single growth factor-ligand pair universally induces DIPG cell invasion. However, our results reveal a potential to create a composite of cytokines or anti-cytokines to modulate DIPG cell invasion.

20.
J Nanosci Nanotechnol ; 21(11): 5583-5591, 2021 11 01.
Article in English | MEDLINE | ID: mdl-33980367

ABSTRACT

Retinyl palmitate (RP) was added in monoolein (MO) cubic phase including decanoyl poly(ethyleneimine) (DePEI) and decanoyl gelatin (DeGel) in its water channel. RP, DePEI, and DeGel was incorporated In the cubic phase without structural disintegration, as confirmed by transmission electron microscopy. Differential scanning calorimetric and polarized optical microscopic analysis showed that adding the additives reduces phase transition temperature of cubic phase by 2 °C to 3 °C. The time-dependent chemical stability of RP added in the cubic phase was analyzed for 4 weeks at 5 °C, 20 °C, 30 °C, and 40 °C, using RP loaded in o/w emulsion as a control. The chemical stability of RP added in cubic phase containing DePEI and DeGel was somewhat higher as compared to the RP added in the cubic phase without DeGel/DePEI, possibly because DeGel/DePEI complex might shield RP from its environment by blocking the water channels inside the cubic phase. Moreover, the chemical stability of RP added in the cubic phase was comparatively higher than RP added in o/w emulsion.

SELECTION OF CITATIONS
SEARCH DETAIL